A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 31, 2025

Study Completion Date

March 31, 2025

Conditions

Renal Cell Carcinoma

Interventions

DEVICE

CyberKnife

Stereotactic Body Radiation Therapy. 3 or 4 fractions of radiotherapy delivered by Cyberknife.

Trial Locations (1)

RECRUITING

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors

collaborator

Dana-Farber Cancer Institute

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER